Driven by Resilient Business Performance, PT Medela Potentia Tbk Receives Bloomberg Indonesia Top Companies Recognition 2026

PT Medela Potentia Tbk (IDX: MDLA) has been honored with the Indonesia Top Companies Recognition 2026 in the "Top Company in Resilient Healthcare Supply Chain & Distribution Excellence" category. The prestigious award, presented by Bloomberg Technoz in collaboration with Indonesia Data, recognizes companies that demonstrate outstanding business performance, strong corporate governance, and resilience in navigating an evolving industry landscape.

The Indonesia Top Companies Recognition 2026 award was presented by Mr. Roger James Finnie, CEO of Bloomberg Technoz, together with Mrs. Winda Mizwar Pratiwi, Founder of Indonesia Data. The award was accepted by Ms. Juliwaty, President Director of PT Medela Potentia Tbk, during the ceremony held at The Westin Jakarta on Monday, June 29, 2026. Also representing the Company at the event was Mr. Edbert Orotodan, Director of PT Medela Potentia Tbk, reaffirming the Company's commitment to strengthening its position as a strategic partner in Indonesia's healthcare industry.

This recognition further reinforces the role of PT Medela Potentia Tbk and its subsidiaries as one of the key pillars of Indonesia's healthcare ecosystem. For more than four decades, the Group has built a broad, reliable, and integrated distribution network to ensure the availability of high-quality healthcare products across the country.

Supported by modern logistics infrastructure, digital technology, artificial intelligence, and a highly competent workforce, PT Medela Potentia Tbk and its subsidiaries continue to deliver reliable, resilient, efficient, and sustainable healthcare solutions that create value for customers and the broader healthcare ecosystem.

Mrs. Juliwaty stated that the award reflects the dedication of the Company's employees and the trust placed in the Company by its business partners.

"We would like to express our sincere appreciation to Bloomberg Technoz and Indonesia Data for this recognition. We also extend our heartfelt gratitude to our customers, principals, business partners, healthcare professionals, regulators, investors, and all stakeholders for their continued trust and collaboration. This award inspires us to continue innovating, strengthening our distribution capabilities, and delivering the highest quality services to improve access to pharmaceutical products and medical devices for communities across Indonesia," said Mrs. Juliwaty.

The recognition also reflects the Company's strong financial performance and continued business growth. In the first quarter of 2026, PT Medela Potentia Tbk recorded revenue of IDR 4.03 trillion, representing solid growth compared with the corresponding period of the previous year.

This performance was driven by the continued expansion of the pharmaceutical distribution and medical device businesses, alongside the strengthening of the Group's increasingly integrated healthcare service capabilities. Strong business fundamentals, disciplined expansion strategies, and a steadfast focus on operational excellence continue to underpin the Company's sustainable growth while creating long-term value for shareholders and all stakeholders.